Toth Financial Advisory’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.73K | Sell |
45
-499
| -92% | -$19.2K | ﹤0.01% | 646 |
|
|
2025
Q1 | $21.1K | Hold |
544
| – | – | ﹤0.01% | 395 |
|
|
2024
Q4 | $18.4K | Hold |
544
| – | – | ﹤0.01% | 404 |
|
|
2024
Q3 | $22.2K | Hold |
544
| – | – | ﹤0.01% | 369 |
|
|
2024
Q2 | $20.9K | Hold |
544
| – | – | ﹤0.01% | 388 |
|
|
2024
Q1 | $23.3K | Sell |
544
-100
| -16% | -$4.29K | ﹤0.01% | 373 |
|
|
2023
Q4 | $23.9K | Buy |
644
+100
| +18% | +$3.71K | ﹤0.01% | 366 |
|
|
2023
Q3 | $19.7K | Hold |
544
| – | – | ﹤0.01% | 370 |
|
|
2023
Q2 | $19.4K | Sell |
544
-20
| -4% | -$713 | ﹤0.01% | 392 |
|
|
2023
Q1 | $20.1K | Hold |
564
| – | – | ﹤0.01% | 382 |
|
|
2022
Q4 | $19.8K | Hold |
564
| – | – | ﹤0.01% | 378 |
|
|
2022
Q3 | $17K | Sell |
564
-28
| -5% | -$844 | ﹤0.01% | 391 |
|
|
2022
Q2 | $32K | Buy |
592
+32
| +6% | +$1.73K | 0.01% | 323 |
|
|
2022
Q1 | $30K | Buy |
+560
| New | +$30K | ﹤0.01% | 336 |
|
|
2021
Q2 | – | Sell |
-80
| Closed | -$4K | – | 708 |
|
|
2021
Q1 | $4K | Buy |
+80
| New | +$4K | ﹤0.01% | 521 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 601 |
|
|
2020
Q3 | – | Sell |
-14
| Closed | -$1K | – | 561 |
|
|
2020
Q2 | $1K | Buy |
+14
| New | +$1K | ﹤0.01% | 494 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 475 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 488 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 477 |
|